The development of tirzepatide involved modifying the native 42-amino acid GIP sequence to incorporate structural elements that confer GLP-1 receptor activity while maintaining GIP receptor agonism
However, patients with higher BMIs may need longer at certain phases before they notice meaningful appetite suppression, which is a normal variation and not a sign the medication is not working.
"Research use only" labeling with weight loss marketing
Diabetic retinopathy in China: epidemiology, screening and treatment trends-a review
Check reviews and pricing
Over the year after withdrawal, participants regained about two thirds of prior weight loss, and improvements in blood pressure, lipids, and glycaemic markers tended to revert toward baseline